Epinephrine - (1mg Base/ml; Solution, Intramuscular, Subcutaneous)

Generic Name	Epinephrine	Innovator	Belcher Pharma
Dosage	1mg Base/ml; Solution, Intramuscular, Subcutaneous	Branded US Sales	Less Than $1000 mn
Probable FTF	None	Known Para IV Filers	None
Other ANDA developers	More Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	Epinephrine is a non-selective alpha and beta adrenergic agonist indicated: • To increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. • For emergency treatment of allergic reactions (Type 1), including anaphylaxis. • For induction and maintenance of mydriasis during intraocular surgery.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
******* (******)	[***(*)*]	**	*** ** ** *** **	********	******** ** *** **, ****
************* ********** ******* ***	[***(*)*]	**	*******	********	******** ** *** **, ****

Chronology Of Events